Workflow
Merit Medical(MMSI)
icon
Search documents
Merit Medical(MMSI) - 2020 Q3 - Earnings Call Transcript
2020-10-29 05:28
Merit Medical Systems, Inc. (NASDAQ:MMSI) Q3 2020 Earnings Conference Call October 28, 2020 5:00 PM ET Company Participants Fred Lampropoulos - Chief Executive Officer Brian Lloyd - Chief Legal Officer Raul Parra - Chief Financial Officer Conference Call Participants Matthew O'Brien - Piper Sandler Jayson Bedford - Raymond James Mike Matson - Needham & Company Steve Lichtman - Oppenheimer Mike Petusky - Barrington Research Jim Sidoti - Sidoti & Company Operator Good afternoon, ladies and gentlemen, and welc ...
Merit Medical(MMSI) - 2020 Q2 - Quarterly Report
2020-08-06 20:51
MERIT MEDICAL SYSTEMS, INC. (Exact name of registrant as specified in its charter) Utah 87-0447695 (State or other jurisdiction of incorporation or organization) (IRS Employer Identification No.) 1600 West Merit Parkway, South Jordan, Utah 84095 Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED June 30, 2020 OR ☐ TRANSITION REPORT PURSUANT ...
Merit Medical(MMSI) - 2020 Q2 - Earnings Call Transcript
2020-07-30 16:34
Merit Medical Systems, Inc. (NASDAQ:MMSI) Q2 2020 Earnings Conference Call July 29, 2020 5:00 PM ET Company Participants Fred Lampropoulos - Chief Executive Officer Brian Lloyd - Chief Legal Officer Raul Parra - Chief Financial Officer Conference Call Participants Larry Biegelsen - Wells Fargo Steve Lichtman - Oppenheimer Cecilia Furlong - Canaccord Mike Petusky - Barrington Research Jayson Bedford - Raymond James Jim Sidoti - Sidoti & Company Mike Matson - Needham & Company Matthew O'Brien - Piper Sandler ...
Merit Medical(MMSI) - 2020 Q1 - Quarterly Report
2020-05-11 19:51
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED March 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO . Commission File Number 0-18592 MERIT MEDICAL SYSTEMS, INC. (Exact name of registrant as specified in its charter) Utah 87-0447695 (State or other ...
Merit Medical(MMSI) - 2020 Q1 - Earnings Call Transcript
2020-04-24 05:54
Merit Medical Systems, Inc. (NASDAQ:MMSI) Q1 2020 Earnings Conference Call April 23, 2020 5:00 PM ET Company Participants Fred Lampropoulos - Chief Executive Officer Brian Lloyd - Chief Legal Officer and Corporate Secretary Raul Parra - Chief Financial Officer Conference Call Participants Shagun Singh - Wells Fargo Securities Michael Matson - Needham & Company, LLC Matthew O???Brien - Piper Sandler Jayson Bedford - Raymond James Financial Steven Lichtman - Oppenheimer & Co. Inc. Cecilia Furlong - Canaccord ...
Merit Medical(MMSI) - 2019 Q4 - Annual Report
2020-03-02 21:40
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended December 31, 2019 or ☐ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. for the transition period from to . Commission File Number 0-18592 MERIT MEDICAL SYSTEMS, INC. (Exact name of registrant as specified in its charter) Utah 87-0447695 (State or ...
Merit Medical(MMSI) - 2019 Q4 - Earnings Call Transcript
2020-02-25 03:45
Merit Medical Systems, Inc. (NASDAQ:MMSI) Q4 2019 Earnings Conference Call February 24, 2020 5:00 PM ET Company Participants Fred Lampropoulos - Chairman & Chief Executive Officer Brian Lloyd - General Counsel Raul Parra - Chief Financial Officer Joe Wright - President, International Justin Lampropoulos - Executive Vice President, Commercial John Knorpp - Chief Regulatory Affairs Officer Conference Call Participants Larry Biegelsen - Wells Fargo Adam Maeder - Piper Sandler Jason Mills - Canaccord Genuity Ja ...
Merit Medical(MMSI) - 2019 Q3 - Quarterly Report
2019-11-08 21:05
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED September 30, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO . Commission File Number 0-18592 MERIT MEDICAL SYSTEMS, INC. (Exact name of registrant as specified in its charter) Utah 87-0447695 (State or ot ...
Merit Medical(MMSI) - 2019 Q3 - Earnings Call Transcript
2019-10-31 05:17
Merit Medical Systems, Inc. (NASDAQ:MMSI) Q3 2019 Earnings Conference Call October 30, 2019 5:00 PM ET Company Participants Fred Lampropoulos ??? Chairman and Chief Executive Officer Brian Lloyd ??? General Counsel Raul Parra ??? Chief Financial Officer Conference Call Participants Jayson Bedford ??? Raymond James Larry Biegelsen ??? Wells Fargo Matthew O???Brien ??? Piper Jaffray Jason Mills ??? Canaccord Bob Hopkins ??? Bank of America Mike Petusky ??? Barrington Research Steven Lichtman ??? Oppenheimer O ...
Merit Medical(MMSI) - 2019 Q2 - Quarterly Report
2019-08-09 17:39
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED June 30, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Registrant's telephone number, including area code: (801) 253-1600 | Title of each class | Trading Symbol | Name of exchange on which registered | | --- | --- | --- | | Common Stock, ...